Breaking News

Nike Says It Has Suspended Contract With Adrian Peterson
Tweet TWEET

Sanofi Selects Medidata Clinical Cloud as a Technology Standard Across Global R&D Organization

  Sanofi Selects Medidata Clinical Cloud as a Technology Standard Across
  Global R&D Organization

  Top 5 Pharma Chooses Medidata Platform for Cutting-Edge Productivity, Cost
         Savings and SaaS Ease-of-Use to Benefit Multiple Trial Areas

Business Wire

NEW YORK & UXBRIDGE, United Kingdom -- October 31, 2012

Medidata Solutions (NASDAQ: MDSO) has been selected by Sanofi, one of the
world’s leading pharmaceutical companies, as the clinical technology standard
for clinical data collection, management and reporting and
performance-enhancing analytics across its entire R&D organization. Sanofi is
actively transitioning to replace some of its existing clinical technologies
with Medidata’s cloud-based solutions across all Sanofi Global R&D as part of
a company-wide initiative to achieve cutting-edge productivity.

Sanofi manages one of the largest R&D organizations in the industry, with a
diverse pipeline in vaccines, diabetes, oncology and orphan drugs, among other
areas. Sanofi is focusing on maximizing the efficiency of its clinical
development organization as well as improving visibility into the progress of
its global trials, and undertook a competitive evaluation of clinical
technology to support its research goals.

  *“Sanofi is involved in a significant amount of the industry’s most
    innovative research, greatly affecting the lives of millions of patients,”
    said Tarek Sherif, CEO, Medidata Solutions. “With the quality, complexity
    and volume of its research efforts comes the challenge of providing its
    R&D teams with the best technology for supporting the full range of its
    clinical studies. In this period of unprecedented change in drug
    development at Sanofi and industry-wide, selecting Medidata substantiates
    the value our solution offers today, improving operational and decision
    effectiveness and thereby accelerating timelines and minimizing costs and
    risk.”

Sanofi will implement Medidata’s electronic data capture, management and
reporting, coding and safety data capture applications. Additionally, the
organization chose Medidata’s clinical business analytics tool to provide
metrics and industry benchmarks that enhances decision-making by executives
and operational managers throughout the trial life cycle.

  *“As leading pharmaceutical companies look to transform their clinical
    development processes to achieve their productivity and revenue goals,
    it’s critical that they select vendors with the right business model,
    global scale and a flexible, feature-rich technology platform that serves
    both their current needs and their vision for the future,” said Sherif.
    “Medidata is excited to be working with Sanofi as it focuses on the next
    phase of its world-class product development.”

Sanofi to Leverage Benefits of Medidata Platform Across R&D Process

Implementation of Medidata’s cloud-based platform will enable Sanofi to
achieve a range of new benefits throughout the trial process and through a
single URL globally:

  *Streamlined trials using the industry’s leading and site-preferred
    electronic data capture and clinical data management tool, Medidata
    Rave^®;
  *Elimination of duplicative safety data capture for improved adverse event
    reporting with Medidata Rave^® Safety Gateway;
  *Centralized coding that simplifies dictionary upgrades and supports
    unlimited coding segments through Medidata Coder™;
  *Earlier insights and more informed decisions through access to clinical
    business analytics and cross-company and cross-industry benchmark
    reporting using Medidata Insights™; and
  *Advanced reporting tools across all global trials, programs and
    geographies accessed through a single URL.

Connect with Medidata:

  *Read our blog, Geeks Talk Clinical
  *Tweet this: Sanofi chooses @Medidata #cloud platform as standard for
    #clinical trials to bring innovative drugs to market faster
    http://bit.ly/RnuQxG
  *Follow us on Twitter: @Medidata
  *Find us on LinkedIn

About Medidata Solutions Worldwide

Medidata Solutions is a leading global provider of cloud-based clinical
development solutions that enhance the efficiency of customers’ clinical
trials. Medidata’s advanced platform lowers the total cost of clinical
development by optimizing clinical trials from concept to conclusion: from
study and protocol design, trial planning and budgeting, site negotiation,
clinical portal, trial management, randomization and trial supply management,
clinical data capture and management, safety events capture, medical coding to
business analytics. Our diverse life science customer base spans
biopharmaceutical companies, medical device and diagnostic companies, academic
and government institutions, CROs and other research organizations, and
includes more than 20 of the top 25 global pharmaceutical companies as well as
organizations of all sizes developing life-enhancing medical treatments and
diagnostics.

Contact:

Medidata Solutions
Lineene Krasnow, 212-918-1761
lkrasnow@mdsol.com
 
Press spacebar to pause and continue. Press esc to stop.